nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Can double-cord transplants provide a more potent graft-vs-leukemia effect?
|
Oran, Betul |
|
2012 |
25 |
4 |
p. 479-482 4 p. |
artikel |
2 |
Can hypomethylating agents provide a platform for curative therapy in myelodysplastic syndromes?
|
Steensma, David P. |
|
2012 |
25 |
4 |
p. 443-451 9 p. |
artikel |
3 |
Can we improve outcomes in patients with acute myelogenous leukemia? Incorporating HDAC inhibitors into front-line therapy
|
Garcia-Manero, Guillermo |
|
2012 |
25 |
4 |
p. 427-435 9 p. |
artikel |
4 |
Does matched unrelated donor transplantation have the same outcome as matched sibling transplantation in unselected patients?
|
Horowitz, Mary M. |
|
2012 |
25 |
4 |
p. 483-486 4 p. |
artikel |
5 |
Editorial Board / Aims & Scope
|
|
|
2012 |
25 |
4 |
p. iii- 1 p. |
artikel |
6 |
Have novel serum markers supplanted tissue diagnosis for invasive fungal infections in acute leukemia and transplantation?
|
Wingard, John R. |
|
2012 |
25 |
4 |
p. 487-491 5 p. |
artikel |
7 |
Have we made progress in the treatment of GVHD?
|
Harris, Andrew C. |
|
2012 |
25 |
4 |
p. 473-478 6 p. |
artikel |
8 |
How close are we to targeting the leukemia stem cell?
|
Pei, Shanshan |
|
2012 |
25 |
4 |
p. 415-418 4 p. |
artikel |
9 |
Improved outcomes with allogeneic hematopoietic cell transplantation
|
Appelbaum, Frederick R. |
|
2012 |
25 |
4 |
p. 465-471 7 p. |
artikel |
10 |
Index
|
|
|
2012 |
25 |
4 |
p. I- 1 p. |
artikel |
11 |
Is it time to revisit standard post-remission therapy?
|
Stone, Richard M. |
|
2012 |
25 |
4 |
p. 437-441 5 p. |
artikel |
12 |
Molecular basis of polycythemic disorders due to aberrant hypoxia sensing and its relevance to acute leukemia
|
Prchal, Josef T. |
|
2012 |
25 |
4 |
p. 493-497 5 p. |
artikel |
13 |
Molecular genetics of AML
|
Link, Daniel C. |
|
2012 |
25 |
4 |
p. 409-414 6 p. |
artikel |
14 |
The changing paradigm of prognostic factors in acute myeloid leukaemia
|
Grimwade, David |
|
2012 |
25 |
4 |
p. 419-425 7 p. |
artikel |
15 |
The impact of mutational profiling on AML prognosis
|
Rowe, Jacob M. |
|
2012 |
25 |
4 |
p. 403-408 6 p. |
artikel |
16 |
What is the impact, present and future, of novel targeted agents in acute lymphoblastic leukemia?
|
Douer, Dan |
|
2012 |
25 |
4 |
p. 453-464 12 p. |
artikel |